Condition: Relapsed or Refractory T Cell Lymphoma · Sponsor: Ono Pharmaceutical Co., Ltd.
This study will investigate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ONO-4685 in patients with relapsed or refractory T cell Lymphoma
This description comes directly from the study's public registry record.
North America Clinical Trial Support Desk · +18665877745(Toll-Free) · clinical_trial@ono-pharma.com
International Clinical Trial Support Desk · +17162141777(Standard) · clinical_trial@ono-pharma.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Completed |
| City of Hope | Duarte, California, United States | Recruiting |
| University of California Irvine Medical Center - Chao Family Comprehensive Cancer Center | Orange, California, United States | Recruiting |
| Stanford Cancer Institute | Palo Alto, California, United States | Recruiting |
| Yale Cancer Center | New Haven, Connecticut, United States | Recruiting |
| Winship Cancer Institute of Emory University | Atlanta, Georgia, United States | Recruiting |
| Dana Farber Cancer Institute | Boston, Massachusetts, United States | Recruiting |
| Karmanos Cancer Institute | Detroit, Michigan, United States | Recruiting |
| Washington University School of Medicine in St. Louis | St Louis, Missouri, United States | Recruiting |
| Hackensack University Medical Center - John Theurer Cancer Center | Hackensack, New Jersey, United States | Recruiting |
| Roswell Park Cancer Institute | Buffalo, New York, United States | Recruiting |
| New York-Presbyterian/Columbia University Irving Medical Center - Herbert Irving Comprehensive Cancer Center (HICCC) | New York, New York, United States | Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05079282